Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Entero Healthcare Solutions Ltd (NSE:ENTERO) delivers strong Q1 FY27 results with record margin expansion, doubling return ratios, and reaffirming its 23% growth guidance.
Entero Healthcare Solutions Ltd (NSE:ENTERO) reports a 42.6% revenue growth in Q4, with strategic plans for continued expansion and profitability in FY27.
Entero Healthcare Solutions Ltd (NSE:ENTERO) reports robust revenue growth and strategic acquisitions, while navigating increased interest costs and integration hurdles.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.